{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:27:46Z","timestamp":1793298466825,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004924","name":"Guangxi Traditional Chinese Medical University","doi-asserted-by":"publisher","award":["2021BS027"],"award-info":[{"award-number":["2021BS027"]}],"id":[{"id":"10.13039\/501100004924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Administration of Traditional Chinese Medicine of Guangxi Zhuang Autonomous Region","award":["GXZYA20220069"],"award-info":[{"award-number":["GXZYA20220069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15567-5","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:53:45Z","timestamp":1768398825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xinmei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"15567_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"15567_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"15567_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69:823\u20139.","journal-title":"Gut"},{"key":"15567_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183163","volume":"16","author":"M Mazurek","year":"2024","unstructured":"Mazurek M, Szewc M, Sitarz MZ, Dudzi\u0144ska E, Sitarz R. Gastric cancer: an up-to-date review with new insights into early-onset gastric cancer. Cancers (Basel). 2024;16:3163.","journal-title":"Cancers (Basel)"},{"key":"15567_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656\u201373.","journal-title":"Nat Rev Clin Oncol"},{"key":"15567_CR6","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","volume":"4","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4:e137-47.","journal-title":"Lancet Public Health"},{"key":"15567_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034635","volume":"102","author":"L Liu","year":"2023","unstructured":"Liu L, Lin J, Zhao J, Yan P. Analysis of clinicopathologic characteristics and prognosis of gastric cancer in patients <40 years. Medicine (Baltimore). 2023;102:e34635.","journal-title":"Medicine (Baltimore)"},{"key":"15567_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1053\/j.gastro.2017.05.012","volume":"153","author":"SY Cho","year":"2017","unstructured":"Cho SY, et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology. 2017;153:536-549.e26.","journal-title":"Gastroenterology"},{"key":"15567_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1634\/theoncologist.2015-0205","volume":"20","author":"N Setia","year":"2015","unstructured":"Setia N, et al. Familial gastric cancers. Oncologist. 2015;20:1365\u201377.","journal-title":"Oncologist"},{"issue":"24","key":"15567_CR10","doi-asserted-by":"publisher","first-page":"00548","DOI":"10.1016\/j.jare.2024.11.028","volume":"S2090\u20131232","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: a retrospective cohort study. J Adv Res. 2024;S2090\u20131232(24):00548\u201354. https:\/\/doi.org\/10.1016\/j.jare.2024.11.028.","journal-title":"J Adv Res"},{"key":"15567_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3892\/ol.2021.12635","volume":"21","author":"Z Ma","year":"2021","unstructured":"Ma Z, et al. Comparative investigation of early-onset gastric cancer. Oncol Lett. 2021;21:374.","journal-title":"Oncol Lett"},{"key":"15567_CR12","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Clinicopathological characteristics and risk factors of young-onset gastric carcinoma: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2024;15:e1.","journal-title":"Clin Transl Gastroenterol"},{"key":"15567_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.33213","volume":"127","author":"N Setia","year":"2021","unstructured":"Setia N, et al. Morphologic and molecular analysis of early-onset gastric cancer. Cancer. 2021;127:103\u201314.","journal-title":"Cancer"},{"key":"15567_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jnci\/djad186","volume":"116","author":"MA Lumish","year":"2024","unstructured":"Lumish MA, et al. Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer. J Natl Cancer Inst. 2024;116:299\u2013308.","journal-title":"J Natl Cancer Inst"},{"key":"15567_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071981","volume":"12","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, et al. High-throughput sequencing of gastric cancer patients: unravelling genetic predispositions towards an early-onset subtype. Cancers (Basel). 2020;12:1981.","journal-title":"Cancers (Basel)"},{"key":"15567_CR16","first-page":"185","volume":"5","author":"K Haruma","year":"2000","unstructured":"Haruma K, et al. Expression of cell cycle regulators and growth factor\/receptor systems in gastric carcinoma in young adults: association with helicobacter pylori infection. Int J Mol Med. 2000;5:185\u201390.","journal-title":"Int J Mol Med"},{"key":"15567_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6517-0","volume":"20","author":"A Moore","year":"2020","unstructured":"Moore A, et al. Young-onset gastric cancer and Epstein-Barr virus (EBV) - a major player in the pathogenesis? BMC Cancer. 2020;20:34.","journal-title":"BMC Cancer"},{"key":"15567_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1498053","volume":"2022","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, et al. Somatic alteration characteristics of early-onset gastric cancer. J Oncol. 2022;2022:1498053.","journal-title":"J Oncol"},{"key":"15567_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/apm.12347","volume":"123","author":"S Gurzu","year":"2015","unstructured":"Gurzu S, et al. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223\u201333.","journal-title":"APMIS"},{"key":"15567_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jso.21281","volume":"99","author":"JC Park","year":"2009","unstructured":"Park JC, et al. Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol. 2009;99:395\u2013401.","journal-title":"J Surg Oncol"},{"key":"15567_CR21","first-page":"2757","volume":"12","author":"X Qu","year":"2022","unstructured":"Qu X, et al. The clinicopathological characteristics of early-onset gastric cancer and its evolutionary trends: a retrospective study. Am J Cancer Res. 2022;12:2757\u201369.","journal-title":"Am J Cancer Res"},{"key":"15567_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.","journal-title":"BMJ"},{"key":"15567_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/modpathol.3800563","volume":"19","author":"ANA Milne","year":"2006","unstructured":"Milne ANA, et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol. 2006;19:564\u201372.","journal-title":"Mod Pathol"},{"key":"15567_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13402-011-0021-0","volume":"34","author":"CB Moelans","year":"2011","unstructured":"Moelans CB, Milne AN, Morsink FH, Offerhaus GJA, van Diest PJ. Low frequency of HER2 amplification and overexpression in early onset gastric cancer. Cell Oncol (Dordr). 2011;34:89\u201395.","journal-title":"Cell Oncol (Dordr)"},{"key":"15567_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s13277-010-0145-2","volume":"32","author":"M Qiu","year":"2011","unstructured":"Qiu M, et al. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol. 2011;32:509\u201314.","journal-title":"Tumour Biol"},{"key":"15567_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jso.23416","volume":"108","author":"C Schildberg","year":"2013","unstructured":"Schildberg C, et al. COX-2, TFF1, and src define better prognosis in young patients with gastric cancer. J Surg Oncol. 2013;108:409\u201313.","journal-title":"J Surg Oncol"},{"key":"15567_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10689-018-0080-8","volume":"18","author":"C Hakkaart","year":"2019","unstructured":"Hakkaart C, et al. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand m\u0101ori. Fam Cancer. 2019;18:83\u201390.","journal-title":"Fam Cancer"},{"key":"15567_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.674224","volume":"11","author":"Q Huang","year":"2021","unstructured":"Huang Q, et al. A distinct clinicopathological feature and prognosis of young gastric cancer patients aged \u2264 45 years old. Front Oncol. 2021;11:674224.","journal-title":"Front Oncol"},{"key":"15567_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1204400","volume":"13","author":"H Chu","year":"2023","unstructured":"Chu H, et al. Clinicopathological characteristics and prognosis of adolescents and young adults with gastric cancer after gastrectomy: a propensity score matching analysis. Front Oncol. 2023;13:1204400.","journal-title":"Front Oncol"},{"key":"15567_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102287","volume":"48","author":"X Han","year":"2024","unstructured":"Han X, et al. A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer. Clin Res Hepatol Gastroenterol. 2024;48:102287.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"15567_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152941","volume":"216","author":"S Choi","year":"2020","unstructured":"Choi S, et al. CDH1 mutations in gastric cancers are not associated with family history. Pathol Res Pract. 2020;216:152941.","journal-title":"Pathol Res Pract"},{"key":"15567_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.advms.2014.03.002","volume":"59","author":"CW Schildberg","year":"2014","unstructured":"Schildberg CW, et al. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Adv Med Sci. 2014;59:142\u20136.","journal-title":"Adv Med Sci"},{"key":"15567_CR33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12609","volume":"21","author":"J Machlowska","year":"2021","unstructured":"Machlowska J, et al. Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer. Oncol Lett. 2021;21:348.","journal-title":"Oncol Lett"},{"key":"15567_CR34","first-page":"667","volume":"21","author":"N Tan","year":"2024","unstructured":"Tan N, et al. Global, regional, and national burden of early-onset gastric cancer. Cancer Biol Med. 2024;21:667\u201378.","journal-title":"Cancer Biol Med"},{"key":"15567_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4251\/wjgo.v9.i5.194","volume":"9","author":"SK Garattini","year":"2017","unstructured":"Garattini SK, et al. Molecular classifications of gastric cancers: novel insights and possible future applications. World J Gastrointest Oncol. 2017;9:194\u2013208.","journal-title":"World J Gastrointest Oncol"},{"key":"15567_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/637308","volume":"2014","author":"X Liu","year":"2014","unstructured":"Liu X, Chu K-M. E-cadherin and gastric cancer: cause, consequence, and applications. BioMed Res Int. 2014;2014:637308.","journal-title":"BioMed Res Int"},{"key":"15567_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejca.2010.10.011","volume":"47","author":"G Corso","year":"2011","unstructured":"Corso G, et al. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631\u20139.","journal-title":"Eur J Cancer"},{"key":"15567_CR38","volume":"17","author":"M Samardali","year":"2025","unstructured":"Samardali M, Samardaly J, Shanti I. A comprehensive literature review of the CDH1 mutation and its role in gastric cancer. Cureus. 2025;17:e85072.","journal-title":"Cureus"},{"key":"15567_CR39","doi-asserted-by":"publisher","first-page":"10477","DOI":"10.2147\/CMAR.S208818","volume":"11","author":"S Shenoy","year":"2019","unstructured":"Shenoy S. CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 2019;11:10477\u201386.","journal-title":"Cancer Manag Res"},{"key":"15567_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/genes9040178","volume":"9","author":"DJ Flanagan","year":"2018","unstructured":"Flanagan DJ, Austin CR, Vincan E, Phesse TJ. Wnt signalling in gastrointestinal epithelial stem cells. Genes. 2018;9:178.","journal-title":"Genes"},{"key":"15567_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.622733","volume":"27","author":"S Lee","year":"2021","unstructured":"Lee S, Kim KM, Lee SY, Jung J. Estrogen aggravates tumor growth in a diffuse gastric cancer xenograft model. Pathol Oncol Res. 2021;27:622733.","journal-title":"Pathol Oncol Res"},{"key":"15567_CR42","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3748\/wjg.v22.i8.2475","volume":"22","author":"MS Ur Rahman","year":"2016","unstructured":"Ur Rahman MS, Cao J. Estrogen receptors in gastric cancer: advances and perspectives. World J Gastroenterol. 2016;22:2475\u201382.","journal-title":"World J Gastroenterol"},{"key":"15567_CR43","volume-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. Version 1.2025","author":"National Comprehensive Cancer Network","year":"2025","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. Version 1.2025. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2025."},{"key":"15567_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021064","volume":"25","author":"E Rubin","year":"2024","unstructured":"Rubin E, et al. Molecular targeting of the human epidermal growth factor receptor-2 (HER2) genes across various cancers. Int J Mol Sci. 2024;25:1064.","journal-title":"Int J Mol Sci"},{"key":"15567_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","volume":"35","author":"AN Bartley","year":"2017","unstructured":"Bartley AN, et al. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the college of American pathologists, American society for clinical pathology, and the American society of clinical oncology. J Clin Oncol. 2017;35:446\u201364.","journal-title":"J Clin Oncol"},{"key":"15567_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051266","volume":"14","author":"V De Re","year":"2022","unstructured":"De Re V, et al. HER2-CDH1 interaction via wnt\/B-catenin is associated with patients\u2019 survival in HER2-positive metastatic gastric adenocarcinoma. Cancers (Basel). 2022;14:1266.","journal-title":"Cancers (Basel)"},{"key":"15567_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3904\/kjim.2005.20.2.116","volume":"20","author":"WH Choe","year":"2005","unstructured":"Choe WH, et al. High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients. Korean J Intern Med. 2005;20:116\u201322.","journal-title":"Korean J Intern Med"},{"key":"15567_CR48","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/labinvest.3780201","volume":"80","author":"M Pinto","year":"2000","unstructured":"Pinto M, et al. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab Invest. 2000;80:1915\u201323.","journal-title":"Lab Invest"},{"key":"15567_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ijc.1454","volume":"94","author":"T Nakajima","year":"2001","unstructured":"Nakajima T, et al. Age-related hypermethylation of the hMLH1 promoter in gastric cancers. Int J Cancer. 2001;94:208\u201311.","journal-title":"Int J Cancer"},{"key":"15567_CR50","first-page":"1989","volume":"11","author":"P Wei","year":"2018","unstructured":"Wei P, Jin M, Zhou X, Hu X, Wang Y. Programmed death-1 and PD-1 ligand-1 expression in early onset gastric carcinoma and correlation with clinicopathological characteristics. Int J Clin Exp Pathol. 2018;11:1989\u201398.","journal-title":"Int J Clin Exp Pathol"},{"key":"15567_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-022-00479-0","volume":"13","author":"\u00c1 Lima","year":"2022","unstructured":"Lima \u00c1, Sousa H, Medeiros R, Nobre A, Machado M. PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discov Oncol. 2022;13:19.","journal-title":"Discov Oncol"},{"key":"15567_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573\u201382.","journal-title":"Nat Genet"},{"key":"15567_CR53","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127\u201331.","journal-title":"N Engl J Med"},{"key":"15567_CR54","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1136\/gutjnl-2019-318640","volume":"69","author":"L Costa","year":"2020","unstructured":"Costa L, et al. USF1 defect drives p53 degradation during helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 2020;69:1582\u201391.","journal-title":"Gut"},{"key":"15567_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2008.36","volume":"21","author":"R Sitarz","year":"2008","unstructured":"Sitarz R, et al. The COX-2 promoter polymorphism -765 G>C is associated with early-onset, conventional and stump gastric cancers. Mod Pathol. 2008;21:685\u201390.","journal-title":"Mod Pathol"},{"key":"15567_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01214","volume":"10","author":"W-H Zhang","year":"2020","unstructured":"Zhang W-H, et al. The significance of the CLDN18-ARHGAP fusion gene in gastric cancer: a systematic review and meta-analysis. Front Oncol. 2020;10:1214.","journal-title":"Front Oncol"},{"key":"15567_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/carcin\/bgx110","volume":"39","author":"Y Ge","year":"2018","unstructured":"Ge Y, et al. Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer. Carcinogenesis. 2018;39:66\u201371.","journal-title":"Carcinogenesis"},{"key":"15567_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4067\/S0716-97602008000300007","volume":"41","author":"C Bernal","year":"2008","unstructured":"Bernal C, et al. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Biol Res. 2008;41:303\u201315.","journal-title":"Biol Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15567-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:03:18Z","timestamp":1770724998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15567-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15567"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15567-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6435874\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}